🌱 KidneyEnergy.com

← brief for 2026-09-26 · Slowing decline

Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension.

Paper No results yet Peer reviewed

Key takeaways

This is a review of new blood pressure drugs for hard-to-control cases. It summarizes existing research but does not report new trial results. It discusses how these drugs might protect kidneys.

Who did this work

Pradhan A · Bhandari M · Singh A · Vishwakarma P · Mahajan K · Perrone MA · Batta A

Source

Paper · PubMed, Losartan and CKD, long-term use · 2026 Sep 7
https://pubmed.ncbi.nlm.nih.gov/42795360/